FDA Adverse Event Injury Summary report: N

MECTACER BIOLOX DELTA FEMORAL BALL HEAD

MDR report key: 22792532 · Received August 13, 2025

Report

Report Number
3005180920-2025-00775
Event Type
Injury
Date Received
August 13, 2025
Date of Event
July 2, 2025
Report Date
August 13, 2025
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
LZO
UDI-DI
07630030809200
PMA / PMN Number
K112115
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 31 JUL 2025. BALL HEADS: MECTACER 01.29.209 MECTACER HEAD BIOLOX DELTA DIA.36 12/14-M (K112115) LOT 146033: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 03-DEC-2014. EXPIRATION DATE: 2019-10-31. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ADDITIONAL COMPONENT INVOLVED IN THE EVENT AND REVISED: BATCH REVIEW PERFORMED ON 31 JUL 2025. MPACT 01.32.3652HCT FLAT PE HC LINER Ø36/G (K103721) LOT. 130419: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 21-MAR-2013. EXPIRATION DATE: 2018-02-28. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. BASED ON THE INFORMATION AVAILABLE NO DEFINITIVE ROOT CAUSE CAN BE ESTABLISHED, WHILE THERE IS NO INDICATION THAT ANY POTENTIAL ISSUE WITH THE DEVICE MAY HAVE CAUSED OR CONTRIBUTED TO THE EVENT, AND THE DEVICE HISTORY RECORD REVIEW DOES NOT INDICATE ANY POTENTIAL MANUFACTURING RELATED ISSUE.

Description of Event or Problem · 0

AT 10 YEARS 4 MONTHS FROM PRIMARY, THE PATIENT CAME IN REPORTING INSTABILITY AND THE CAUSE IS UNKNOWN. THE SURGEON REVISED THE HEAD AND LINER (FROM Ø36 TO Ø40) AND THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
66081 MECTACER BIOLOX DELTA FEMORAL BALL HEAD FEMORAL HEAD Ø 36 SIZE M LZO MEDACTA INTERNATIONAL SA 01.29.209 146033 07630030809200

Patients

Seq Age Sex Outcome Treatment
1 75 YR Male Required Intervention